drugset / Trial / NCT03228433
A Study to Evaluate Safety, Tolerability and Pharmacokinetics of Ascending Oral Single Dose of TAK-418 in Healthy Participants
RandomizedSequentialQuadruple-blindOther
Summary
The purpose of this study is to evaluate the safety and tolerability of TAK-418 following single oral doses in healthy participants.
Timeline
- Start
- 2017-07-21
- Primary completion
- 2018-05-12
- Completion
- 2018-05-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | TAK-418 | Small molecule | 5 mg | Oral |
| Subject | TAK-418 | Small molecule | 15 mg | Oral |
| Subject | TAK-418 | Small molecule | 30 mg | Oral |
| Subject | TAK-418 | Small molecule | 40 mg | Oral |
| Subject | TAK-418 | Small molecule | 60 mg | Oral |
Indications
No indication recorded.